Risk of cancer in patients treated with human pituitary growth hormone in the UK, 1959–85: a cohort study

This publication has 22 references indexed in Scilit:

• High-risk colorectal adenomas and serum insulin-like growth factors
  British Journal of Surgery, 2001
• Colorectal neoplasia in acromegaly: the reported increased prevalence is overestimated Reply
  Gut, 2000
• Recent Status in the Occurrence of Leukemia in Growth Hormone-Treated Patients in Japan
  Journal of Clinical Endocrinology & Metabolism, 1999
• Circulating concentrations of insulin-like growth factor I and risk of breast cancer
  The Lancet, 1998
• Safety of Growth Hormone after Treatment of a Childhood Malignancy
  Hormone Research, 1995
• Blockade of the insulin‐like growth‐factor‐I receptor inhibits growth of human colorectal cancer cells: Evidence of a functional IGF‐II‐mediated autocrine loop
  International Journal of Cancer, 1994
• The ratio between serum levels of insulin‐like growth factor (IGF)‐I and the IGF binding proteins (IGFBP‐1, 2 and 3) decreases with age in healthy adults and is increased in acromegalic patients
  Clinical Endocrinology, 1994
• Mortality, neoplasia, and Creutzfeldt-Jakob disease in patients treated with human pituitary growth hormone in the United Kingdom.
  BMJ, 1991
• Premature mortality due to cardiovascular disease in hypopituitarism
  The Lancet, 1990
• TREATMENT OF A PITUITARY DWARF WITH HUMAN GROWTH HORMONE*
  Journal of Clinical Endocrinology & Metabolism, 1958